Delivery Order SPE2DB20D2014-SPE2DB24FB46J
Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,605,047 units of the pharmaceutical product Omeprazole DR 40 mg capsules. The contract has a completion date of February 9, 2024 and a potential value of $1,244.88. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, which has a potential value of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,439,417 units of Omeprazole DR 40 mg capsules. The contract has a completion date of January 26, 2024 and a potential value of $1,485.15. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside contract. This delivery order is issued under an Indefinite...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,085.46, is for the supply of 4,564,083,798 units of Omeprazole DR 40 mg capsules. This delivery order was issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31,...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.74 firm fixed-price delivery order is for 4,564,839,898 units of Omeprazole DR 20 mg capsules. The contract has an ultimate completion date of June 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Omeprazole DR 40 mg capsules (90-count unit) on July 25, 2025, with a ceiling value of $1,083.09 and an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,563,489,920 units of Omeprazole DR 40 mg capsules. The contract has a potential value of $1,429.64 and a completion date of January 31, 2024. The award is not associated with any set-aside programs. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,564,491,273 units of Omeprazole DR 40 mg capsules. The $2,879.26 firm fixed price Delivery Order was awarded on May 3, 2024 by the Defense Logistics Agency (DLA) and has a completion date of May 6, 2024. The contract is not set aside and represents a small portion of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 1,000 units of Omeprazole DR 40 mg capsules, with a completion date of February 8, 2024 and a potential value of $4,155.23. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite...
- This federal contract award is for the delivery of 4,565,165,305 units of omeprazole DR 20 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,111.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 17, 2024 and is a firm fixed-price delivery order. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $3,018.32 delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 omeprazole DR 40 mg capsules, with an ultimate completion date of August 26, 2025. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The omeprazole supply supports federal medical procurement needs for military and veteran healthcare...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB46JDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,109,613 units of Omeprazole DR 40 mg capsules. The award, valued at $1,014.51, has a period of performance through March 29, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and programs. The IDC has a potential value of $999,999,999.00 and is in effect through December 31, 2025. No set-aside designations were used for this award.
Generated 6/27/24, 10:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/28/24 |